CAS No.
[1095598-84-7 (Freebase)]
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl-D4]-a-a-diphenyl-3- pyrrolidineacetamide; Hydrochloride
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Darifenacin-d4 Hydrochloride is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Darifenacin-d4 Hydrochloride usage and description
Darifenacin D4 hydrochloride is a medication that is used to treat overactive bladder (OAB) symptoms such as urinary urgency, frequency, and incontinence. It is a selective M3 muscarinic receptor antagonist that works by blocking the neurotransmitter acetylcholine from binding to the M3 receptors in the bladder, leading to a decrease in bladder contractions and an increase in bladder capacity.
Chemically, Darifenacin D4 hydrochloride is a deuterated form of Darifenacin hydrochloride, which means that it contains four deuterium atoms instead of hydrogen atoms. Deuterium is a non-radioactive isotope of hydrogen that can be used in drug development to improve pharmacokinetic properties such as bioavailability and metabolic stability.
The recommended dosage of Darifenacin D4 hydrochloride is 7.5 mg once daily, and it is available in tablet form for oral administration. The medication should be taken with water and swallowed whole, and it should not be crushed or chewed.
Like all medications, Darifenacin D4 hydrochloride may cause side effects such as dry mouth, constipation, blurred vision, and urinary retention. It may also interact with other medications such as ketoconazole, erythromycin, and rifampin.
In conclusion, Darifenacin D4 hydrochloride is a selective M3 muscarinic receptor antagonist used to treat overactive bladder symptoms. It is chemically similar to Darifenacin hydrochloride but contains deuterium atoms, and it should be taken as directed by a healthcare provider.
